- Home
- RGLS vs ELTK Comparison
RGLS vs ELTK Comparison
Compare RGLS & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- ELTK
- Stock Information
- Founded
- RGLS 2007
- ELTK 1970
- Country
- RGLS United States
- ELTK Israel
- Employees
- RGLS N/A
- ELTK N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- ELTK Electrical Products
- Sector
- RGLS Health Care
- ELTK Technology
- Exchange
- RGLS Nasdaq
- ELTK Nasdaq
- Market Cap
- RGLS 74.0M
- ELTK 73.9M
- IPO Year
- RGLS 2012
- ELTK 1997
- Fundamental
- Price
- RGLS $1.31
- ELTK $11.14
- Analyst Decision
- RGLS Strong Buy
- ELTK
- Analyst Count
- RGLS 6
- ELTK 0
- Target Price
- RGLS $10.33
- ELTK N/A
- AVG Volume (30 Days)
- RGLS 820.1K
- ELTK 10.9K
- Earning Date
- RGLS 03-20-2025
- ELTK 03-10-2025
- Dividend Yield
- RGLS N/A
- ELTK 1.98%
- EPS Growth
- RGLS N/A
- ELTK N/A
- EPS
- RGLS N/A
- ELTK 0.85
- Revenue
- RGLS N/A
- ELTK $48,090,000.00
- Revenue This Year
- RGLS N/A
- ELTK $7.47
- Revenue Next Year
- RGLS N/A
- ELTK $9.96
- P/E Ratio
- RGLS N/A
- ELTK $13.10
- Revenue Growth
- RGLS N/A
- ELTK 7.22
- 52 Week Low
- RGLS $0.83
- ELTK $9.00
- 52 Week High
- RGLS $3.79
- ELTK $14.52
- Technical
- Relative Strength Index (RSI)
- RGLS 53.78
- ELTK 47.59
- Support Level
- RGLS $1.22
- ELTK $11.05
- Resistance Level
- RGLS $1.60
- ELTK $11.60
- Average True Range (ATR)
- RGLS 0.13
- ELTK 0.40
- MACD
- RGLS 0.03
- ELTK -0.01
- Stochastic Oscillator
- RGLS 50.85
- ELTK 54.90
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.